Literature DB >> 13250424

Chlorpromazine alone and with reserpine; use in the treatment of mental diseases.

L E HOLLISTER, K P JONES, B BROWNFIELD, F JOHNSON.   

Abstract

One hundred psychiatric patients were treated with chlorpromazine, alone or combined with reserpine. Fifty-six per cent of patients with chronic schizophrenic reactions showed moderate or pronounced improvement when treated with chlorpromazine alone. The results of treatment with the combined drugs were not so good as that. Indications are that treatment of patients with chronic schizophrenic reactions is more efficacious with these drugs than with other forms of somatic therapy. Complications of treatment were far greater with combined use of chlorpromazine and reserpine. For this reason, the combination appears to have limited usefulness. The Parkinson syndrome was the most frequent complication of large doses of these drugs. It appears to be a toxic reaction, requiring reduction in dosage. Jaundice appears to be neither a frequent nor a serious complication of treatment.

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy; RAUWOLFIA ALKALOIDS/therapeutic use

Mesh:

Substances:

Year:  1955        PMID: 13250424      PMCID: PMC1532707     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  7 in total

1.  Combined reserpine-chlorpromazine therapy in disturbed psychotics.

Authors:  J A BARSA; N S KLINE
Journal:  Am J Psychiatry       Date:  1955-04       Impact factor: 18.112

2.  Treatment of psychotic states with chlorpromazine.

Authors:  D GOLDMAN
Journal:  J Am Med Assoc       Date:  1955-04-09

3.  Treatment of chronic schizophrenic reactions with reserpine.

Authors:  L E HOLLISTER; G E KRIEGER; A KRINGEL; R H ROBERTS
Journal:  Ann N Y Acad Sci       Date:  1955-04-15       Impact factor: 5.691

4.  Clinical use of reserpine in psychiatry: comparison with chlorpromazine.

Authors:  M BLEULER; W A STOLL
Journal:  Ann N Y Acad Sci       Date:  1955-04-15       Impact factor: 5.691

5.  Chlorpromazine in the treatment of neuropsychiatric disorders.

Authors:  N W WINKELMAN
Journal:  J Am Med Assoc       Date:  1954-05-01

6.  Chlorpromazine; new inhibiting agent for psychomotor excitement and manic states.

Authors:  H E LEHMANN; G E HANRAHAN
Journal:  AMA Arch Neurol Psychiatry       Date:  1954-02

7.  Jaundice caused by chlorpromazine (thorazine).

Authors:  R L LOFTUS; K A HUIZENGA; M H STAUFFER; H P ROME; J C CAIN
Journal:  J Am Med Assoc       Date:  1955-04-09
  7 in total
  2 in total

1.  Inadequacies in the reporting of clinical drug research.

Authors:  B S GLICK
Journal:  Psychiatr Q       Date:  1963-04

2.  Thioridazine (mellaril) in psychiatric patients.

Authors:  L E HOLLISTER; B F MACDONALD
Journal:  Calif Med       Date:  1959-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.